ELX/TEZ/IVA (elexacaftor/tezacaftor/ivacaftor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ELX/TEZ/IVA (elexacaftor/tezacaftor/ivacaftor), covering 2025-05-18 to 2025-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA TC Combination Therapy in Participants With Cystic Fibrosis Who Are 6 Years of Age and Older [Phase 3]